OptimizeRx Corporation (OTCMKTS:OPRX) Files An 8-K Other Events
Item 8.01 Other Events
On March 8, 2017, the Company held a conference call to discuss
the Companys 2016 year-end earnings and other matters of
business, a transcript of which is furnished herewith as Exhibit
99.1 and is incorporated herein by reference.
The information in Item 8.01 of this Current Report on Form 8-K
(including Exhibit 99.1) shall not be deemed filed for purposes
of Section 18 of the Securities Exchange Act of 1934 (the
Exchange Act) or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933 or the Exchange Act,
except as expressly set forth by specific reference in such a
filing.
Section 9 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
| 99.1 | Conference call transcript dated March 8, 2017 |
About OptimizeRx Corporation (OTCMKTS:OPRX)
OptimizeRx Corporation is a technology solutions company. The Company focuses on the healthcare industry. The Company connects patients, physicians and pharmaceutical manufacturers through technology. The Company’s solutions provide pharmaceutical manufacturers a direct to physician channel for communicating and promoting products. It provides healthcare providers a means to provide sampling and coupons without having to physically store samples on site. The Company’s principal products and applications include SampleMD, OPTIMIZEHR and OPTIMIZERx.com. SampleMD is a virtual Patient Support Center. OPTIMIZEHR is a consulting practice focused on educating and working with pharmaceutical manufacturers on identifying, formulating and implementing new electronic prescribing (eRx) media strategies for promoting their products. OPTIMIZERx.com is a portal to healthcare savings for patients to centrally review and participate in prescription and healthcare savings and support programs. OptimizeRx Corporation (OTCMKTS:OPRX) Recent Trading Information
OptimizeRx Corporation (OTCMKTS:OPRX) closed its last trading session up +0.062 at 0.802 with 30,200 shares trading hands.
